Abstract Body

Background: Despite the diverse quasispecies of HIV-1 in the transmitting partner, a bottleneck occurs during transmission whereby, in general, a single genetic variant from that quasispecies establishes infection in the new host. The current working model explaining the transmission bottleneck suggests that transmitted/founder (TF) variants have a higher in vivo fitness and are preferentially resistant to the innate antiviral effects of interferon alpha (IFNα), enabling escape from the early innate immune response. However, variants derived from HIV-1 transmission pairs with the full complement of HIV proteins have yet to be tested for IFNα resistance or in vitro replication. In this study, we assess replication and IFNα resistance of infectious molecular clones derived from both partners from six transmission pairs to compare the TF to non-transmitted (NT) variants that were present near the time of transmission.

Methods: Using a novel cloning strategy, we generated 44 HIV-1 subtype-C full-length infectious molecular clones (6 TF & 38 non-transmitted (NT) variants) from plasma of 6 linked transmission pairs near the time of transmission from the Zambia-Emory HIV Research Project (ZEHRP). The NT variants were selected to represent the sequence diversity of the transmitting partner. We measured virus growth in stimulated PBMC and compared the levels of replication in the presence and absence of IFNα to determine IFNα resistance of the TF and NT variants.

Results: We found no evidence of selection for IFNα resistance during heterosexual transmission (p=0.7813), when comparing the TF to matched NT variants. We also did not observe selection for TF varaints with higher in vitro replicative capacity than the median of the matched NT variants (p=0.7118). Notably, the in vitro replicative capacity of each variant correlated with the ability to replicate in the face of IFNα (p<0.0001) and replicative capacity correlated negatively with IFNα resistance (p<0.0001).

Conclusions: Our results emphasize the importance of comparing TF variants to NT controls near the time of transmission and suggest that IFNα resistance and in vitro replicative capacity are not necessarily selected for during transmission of subtype C HIV-1 variants. Further characterization of TF variants is necessary to fully understand the viral properties selected for during the HIV-1 transmission bottleneck and to optimize protection through vaccines or other prevention modalities.